Last updated: March 29, 2025
Sponsor: Indonesia University
Overall Status: Active - Recruiting
Phase
4
Condition
Diabetes Mellitus, Type 2
Diabetes Prevention
Diabetes And Hypertension
Treatment
Placebo
Propolis drops
Clinical Study ID
NCT06903546
24-10-1677
Ages 35-59 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Controlled Diabetes Mellitus type 2 with HbA1c <7.5%
BMI 23-35 kg/m2
On anti-cholesterol therapy
Exclusion
Exclusion Criteria:
Using injection therapy (insulin or GLP-1 RA)
History of bees product allergy
Active smoker
Consuming alcohol
Altered liver (ALT>35 IU/L) and kidney (eGFR<90 mL/min) function
Pregnant and breastfeeding women
History of cardiovascular disease (heart attack, stroke)
Study Design
Total Participants: 64
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 4
Study Start date:
March 18, 2025
Estimated Completion Date:
July 31, 2025
Study Description
Connect with a study center
University of Indonesia Faculty of Biomedical Science
Jakarta, 10430
IndonesiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.